Laparoscopic gastric bypass results in decreased prescription medication costs within 6 months

Gould, Jon Charles; Garren, Michael Joseph; Starling, James Ralph
December 2004
Journal of Gastrointestinal Surgery;Dec2004, Vol. 8 Issue 8, p983
Academic Journal
journal article
The prevalence of obesity has reached epidemic proportions. The treatment of obesity-related health conditions is costly. Although laparoscopic gastric bypass is expensive, health care costs in obese patients should decrease with subsequent weight loss and overall improved health. Specifically, monthly prescription medication costs should decrease quickly after surgery. Fifty consecutive laparoscopic gastric bypass patients at a university-based bariatric surgery program were enrolled in the study. Medication consumption was prospectively recorded in a database. Patients'' monthly prescription (not over-the-counter) medication costs before surgery and 6 months postoperatively were calculated. Retail costs were determined by a query to drugstore.com, an online pharmacy. Generic drugs were selected when appropriate. Costs for diabetic supplies and monitoring were not included in this analysis. Patients were mostly female (86%). Mean body mass index preoperatively was 51 kg/m2. Mean excess weight loss at 6 months was 52%. Patients took an average of 3.7 prescription medications before surgery compared with 1.7 after surgery (P < 0.05). All patients took nonprescription nutritional supplements, including multivitamins, oral vitamin B12, and calcium postoperatively. Laparoscopic gastric bypass resulted in a significant improvement in comorbid health conditions as early as 6 months after surgery. In an unselected group of patients, this led to a substantial overall mean monthly prescription medication cost savings, especially in those with gastroesophageal reflux disease, hypertension, diabetes, and hypercholesterolemia.


Related Articles

  • Weight Loss after Sleeve Gastrectomy in Super Superobesity. Catheline, J.-M.; Fysekidis, M.; Dbouk, R.; Boschetto, A.; Bihan, H.; Reach, G.; Cohen, R. // Journal of Obesity;2012, Vol. 2012, p1 

    Objective. This prospective study evaluated laparoscopic sleeve gastrectomy for its safety and efficiency in excess weight loss (%EWL) in super superobese patients (BMI > 60 Kg/m2). Results. Thirty patients (33 women and 7 men) were included, with mean age of 35 years (range 18 to 59).Mean...

  • Bariatric Outcomes Longitudinal Database (BOLD) Suggests Excess Weight Loss and Excess BMI Loss To Be Inappropriate Outcome Measures, Demonstrating Better Alternatives. Laar, Arnold // Obesity Surgery;Dec2012, Vol. 22 Issue 12, p1843 

    Excess weight loss (%EWL) results show significant variation by initial body mass index (BMI): the heavier the patient, the lower the result. It is unclear whether this effect originates from the arithmetic construction of this outcome measure or from any true difference in bariatric impact on...

  • Socioeconomic predictors of weight loss after laparoscopic Roux-Y gastric bypass. Akkary, Ehab; Nerlinger, Abby; Sunkyung Yu; Dziura, James; Duffy, Andrew J.; Bell, Robert L. // Surgical Endoscopy;Jun2009, Vol. 23 Issue 6, p1246 

    Successful weight loss after laparoscopic Roux-Y gastric bypass (LRYGB) hinges on many elements including neurohormonal, anatomical, and postoperative behavioral changes. To date, the effects of socioeconomic factors have been inadequately studied. We examine several components of socioeconomic...

  • Laparoscopic Roux-en-Y gastric bypass: long term clinical outcomes. Obeid, Ayman; Long, Joshua; Kakade, Manasi; Clements, Ronald; Stahl, Richard; Grams, Jayleen // Surgical Endoscopy;Dec2012, Vol. 26 Issue 12, p3515 

    Background: Bariatric surgery remains the most effective treatment for morbid obesity, and laparoscopic Roux-en-Y gastric bypass (LRYGB) continues to be the preferred operation. However, data for long-term outcomes are lacking. Our goal was to determine the long-term clinical outcomes after...

  • Bypass gástrico en el tratamiento de la obesidad mórbida y la superobesidad: estudio comparativo. Carvajal-Balaguera, J.; García-Almenta, M. Martín; de Torres, S. Oliart Delgado; Camuñas-Segovia, J.; Peña-Gamarra, L.; Fernández, I. P.; Gómez-Maestro, P.; Sánchez, A. Prieto; Viso-Ciudad, S.; Cerquella-Hernández, C. M. // Nutricion Hospitalaria;sep2007, Vol. 22 Issue 5, p607 

    Introduction: Gastric Bypass (GB) constitutes the surgical treatment of election of morbid obesity (BMI < 50) at the present time, however doubts exist about its effectiveness in super obesity patients (BMI > 50). Objective: The purpose of this work is one of to analyze the results of loss of...

  • Laparoscopic Sleeve Gastrectomy is a Safe and Effective Bariatric Procedure for the Lower BMI (35.0-43.0 kg/m) Population. Gluck, Brian; Movitz, Blake; Jansma, Shannon; Gluck, Jennifer; Laskowski, Kelly // Obesity Surgery;Aug2011, Vol. 21 Issue 8, p1168 

    Background: The laparoscopic vertical sleeve gastrectomy (LSG) is derived from the biliopancreatic diversion with duodenal switch operation (Marceau et al., Obes Surg 3:29-35, ; Hess and Hess, Obes Surg 8:267-82, ; Chu et al., Surg Endosc 16:S069, ). Later, LSG was advocated as the first step of...

  • Clinical-nutritional evolution of older women submitted to roux-en-y gastric bypass. Ribeiro de Moraes, Mayanne; de Mendonça Soares, Bruna Lúcia; Maio, Regiane; Pessoa de Araújo Burgos, Maria Goretti // Nutricion Hospitalaria;mar2015, Vol. 31 Issue 3, p1330 

    The aim of the present study was to describe the clinical- nutritional evolution of older women submitted to Roux-en-Y gastric bypass surgery. A concurrent, retrospective study was conducted involving a sample of 16 older women with morbid obesity submitted to Rouxen- Y gastric bypass surgery...

  • Valoración de la evolución de las comorbilidades de la obesidad mórbida tras tratamiento quirúrgico mediante la técnica del cruce duodenal. Prado, A. Vázquez; Orón, E. M. Montalvá; de Tursi Ríspoli, L. C. // Nutricion Hospitalaria;sep2007, Vol. 22 Issue 5, p596 

    Objective. To assess the impact of weight loss in clinical progression of the comorbidities in a group of morbid obese patients submitted to surgical treatment with the duodenal switch technique. Study setting. Between 2001-2006, we have operated by the duodenal crossing technique a total of 118...

  • Does establishing a bariatric surgery fellowship training program influence operative outcomes? Gonzalez, R.; Nelson, L. G.; Murr, M. M. // Surgical Endoscopy;Jan2007, Vol. 21 Issue 1, p109 

    Background: Roux-en-Y gastric bypass (RYGB) has a long learning curve that may be reflected in operative outcomes. This study sought to assess whether training a fellow has an impact on the operative outcomes of the training program.Methods: Prospectively collected data...

  • Comorbidities Remission After Roux-en-Y Gastric Bypass for Morbid Obesity is Sustained in a Long-Term Follow-up and Correlates with Weight Regain. Neto, Rafael; Herbella, Fernando; Tauil, Renato; Silva, Fabricio; Lima, Sizenando // Obesity Surgery;Oct2012, Vol. 22 Issue 10, p1580 

    Background: Obesity-related comorbidities are treated by Roux-en-Y gastric bypass (RYGB) due to weight loss and intestinal hormone changes. Few studies report the evolution of these comorbidities in a long-term follow-up, especially if weight regain is present. This study aims to analyze: (1)...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics